Eye Tracking Leader NKI is a world leader in eye tracking technology and non-invasive neuro-otologic diagnostic testing, serving clinicians globally. Sales opportunities exist in expanding device adoption among audiologists, ENT specialists, neuro-otologists, neuro-ophthalmologists, neurologists, physical therapists, and chiropractors who rely on eye movement data for diagnosis.

I-Portal Platform Current products center on the I-Portal suite (NOTC System, VNG, VOG) with associated accessories, software, training and support. Upsell and cross-sell opportunities include accessories, software add-ons, extended training packages, and value-based service contracts to deepen platform stickiness.

Regional Growth Located in Pittsburgh with a global customer base and over 25 years in the market, NKI is positioned to expand geographic reach. Target growth by expanding direct sales in underserved regions, building local partnerships, and showcasing outcomes to drive clinical adoption.

Financial Signals Revenue is in the low to mid single-digit millions with recent debt financing activity and leadership additions (e.g., Vice President of Sales). This suggests capacity for scaled marketing, larger sales initiatives, and channel development to accelerate revenue growth.

Strategic Partnerships The technology interfaces and clinical focus align with hospitals, clinics, and multidisciplinary centers. Opportunities exist to pursue collaborations with larger medical device distributors, academic research programs, and integrated care networks to broaden usage of eye-tracking diagnostic tools.